Aerie Pharmaceuticals.

Aerie Pharmaceuticals raised $316.5 million in a convertible notes offering. The company plans to use the funds to continue development of treatments for eye diseases.

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT